NONUREMIC INDICATION FOR PERITONEAL DIALYSIS FOR REFRACTORY HEART FAILURE IN CARDIORENAL SYNDROME TYPE II: REVIEW AND PERSPECTIVE

被引：14

作者：

Nakayama, Masaaki ^{[1
]}

机构：

[1] Fukushima Med Univ, Sch Med, Dept Hypertens & Nephrol, Fukushima 9601295, Japan

来源：

PERITONEAL DIALYSIS INTERNATIONAL | 2013年 / 33卷 / 01期

关键词：

Congestive heart failure; cardiorenal syndrome type II; nonuremic indications; CHRONIC-RENAL-FAILURE; THERAPEUTIC APPROACH; CARDIAC-FAILURE; FLUID OVERLOAD; ULTRAFILTRATION; MANAGEMENT; RESISTANT; DISEASE; CONGESTION; MECHANISMS;

D O I：

10.3747/pdi.2012.00014

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiorenal syndrome (CRS) type II is a serious condition in which chronic cardiac abnormalities cause worsening kidney function, leading to permanent chronic kidney damage. Management of CRS type II coupled with diuretic-resistant congestive heart failure (CHF) has been an issue of dispute. However, since the early 1990s, reports indicating the clinical usefulness of peritoneal dialysis (PD) as maintenance therapy for intractable CHF in this population have been accumulating. The present manuscript reviews the mechanisms by which kidney dysfunction develops within CHF, and then examines recent experiences of PD as chronic supportive therapy for intractable CRS type II, reviews the contributing mechanisms, and discusses the rationale for using PD as a new therapeutic approach in the nonuremic setting of CHF. Perit Dial Int 2013; 33( 1):8-14 www.PDIConnect.com doi:10.3747/pdi.2012.00014

引用

页码：8 / 14

页数：7